# Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine

> **NCT00743340** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 50 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** Emtricitabine

## Key facts

- **NCT ID:** NCT00743340
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-22
- **Primary completion:** 2017-02-13
- **Final completion:** 2017-02-13
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00743340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00743340, "Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00743340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*